[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxgAAN4Mnzsda5Yhir4me_eCOn30O-nluxSIfFfTKbJM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":45,"rows":52},"Kahramanmaras Sutcu Imam University",[4],179,false,36,0,16566,3,172,[14,17,20,22,24,26,29,32],{"name":15,"count":16},"Cerebral Palsy",11,{"name":18,"count":19},"Anxiety",7,{"name":21,"count":19},"Pain, Postoperative",{"name":23,"count":19},"Multiple Sclerosis",{"name":25,"count":19},"Postoperative Pain",{"name":27,"count":28},"Pain",6,{"name":30,"count":31},"PARKINSON DISEASE (Disorder)",4,{"name":33,"count":31},"Infant Development",[35,40],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT06866054","Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery","2025-08-30","SPSIPB block",{"nctId":41,"briefTitle":42,"date":43,"intervention":44},"NCT07409571","Palatal Wound Healing After Free Gingival Graft Surgery","2026-05-20","triamcinolone acetonide",[46,47,48,49,50,51],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[53,78,96,119,147,175,193,219,246],{"intervention":39,"totalTrials":54,"cells":55},1,{"EARLY_PHASE1":56,"PHASE1":58,"PHASE2":60,"PHASE3":62,"PHASE4":64,"NA":66},{"trials":57,"activeCount":9},[],{"trials":59,"activeCount":9},[],{"trials":61,"activeCount":9},[],{"trials":63,"activeCount":9},[],{"trials":65,"activeCount":9},[],{"trials":67,"activeCount":54,"soonestReadout":38},[68],{"nctId":36,"briefTitle":37,"status":69,"phases":70,"primaryCompletion":38,"completion":38,"start":71,"enrollment":72,"conditions":73,"interventions":76},"RECRUITING",[51],"2025-04-10",50,[74,75],"Shoulder Pain","Shoulder Injuries",[39,77],"Postoperative analgesia management",{"intervention":77,"totalTrials":54,"cells":79},{"EARLY_PHASE1":80,"PHASE1":82,"PHASE2":84,"PHASE3":86,"PHASE4":88,"NA":90},{"trials":81,"activeCount":9},[],{"trials":83,"activeCount":9},[],{"trials":85,"activeCount":9},[],{"trials":87,"activeCount":9},[],{"trials":89,"activeCount":9},[],{"trials":91,"activeCount":54,"soonestReadout":38},[92],{"nctId":36,"briefTitle":37,"status":69,"phases":93,"primaryCompletion":38,"completion":38,"start":71,"enrollment":72,"conditions":94,"interventions":95},[51],[74,75],[39,77],{"intervention":44,"totalTrials":54,"cells":97},{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":106,"NA":108},{"trials":99,"activeCount":9},[],{"trials":101,"activeCount":9},[],{"trials":103,"activeCount":9},[],{"trials":105,"activeCount":9},[],{"trials":107,"activeCount":9},[],{"trials":109,"activeCount":54,"soonestReadout":43},[110],{"nctId":41,"briefTitle":42,"status":69,"phases":111,"primaryCompletion":43,"completion":43,"start":112,"enrollment":113,"conditions":114,"interventions":118},[51],"2025-10-16",55,[115,116,117],"Gingival Recession, Localized","Postoperative Morbidity","Palatal Donor Site Wound Healing",[44],{"intervention":120,"totalTrials":54,"cells":121},"Bupivacaine",{"EARLY_PHASE1":122,"PHASE1":124,"PHASE2":126,"PHASE3":128,"PHASE4":130,"NA":145},{"trials":123,"activeCount":9},[],{"trials":125,"activeCount":9},[],{"trials":127,"activeCount":9},[],{"trials":129,"activeCount":9},[],{"trials":131,"activeCount":9},[132],{"nctId":133,"briefTitle":134,"status":135,"phases":136,"primaryCompletion":137,"completion":138,"start":139,"enrollment":140,"conditions":141,"interventions":144},"NCT02990702","Retroclavicular Approach vs Infraclavicular Approach for Brachial Plexus Block in Obese Patients","UNKNOWN",[50],"2017-05","2017-07","2017-01",60,[142,143],"Forearm Injuries","Hand Injuries",[120],{"trials":146,"activeCount":9},[],{"intervention":148,"totalTrials":54,"cells":149},"Cipro 400 MG in 200 ML",{"EARLY_PHASE1":150,"PHASE1":152,"PHASE2":154,"PHASE3":156,"PHASE4":158,"NA":160},{"trials":151,"activeCount":9},[],{"trials":153,"activeCount":9},[],{"trials":155,"activeCount":9},[],{"trials":157,"activeCount":9},[],{"trials":159,"activeCount":9},[],{"trials":161,"activeCount":9},[162],{"nctId":163,"briefTitle":164,"status":165,"phases":166,"primaryCompletion":167,"completion":167,"start":168,"enrollment":169,"conditions":170,"interventions":173},"NCT04462588","Immature Granulocyte [IG] Count and Percentage for Medical Treatment of Uncomplicated Acute Appendicitis","COMPLETED",[],"2020-06-01","2019-06-01",64,[171,172],"Acute Appendicitis Without Peritonitis","Medical Emergencies",[148,174],"Flagyl I.V. RTU",{"intervention":174,"totalTrials":54,"cells":176},{"EARLY_PHASE1":177,"PHASE1":179,"PHASE2":181,"PHASE3":183,"PHASE4":185,"NA":187},{"trials":178,"activeCount":9},[],{"trials":180,"activeCount":9},[],{"trials":182,"activeCount":9},[],{"trials":184,"activeCount":9},[],{"trials":186,"activeCount":9},[],{"trials":188,"activeCount":9},[189],{"nctId":163,"briefTitle":164,"status":165,"phases":190,"primaryCompletion":167,"completion":167,"start":168,"enrollment":169,"conditions":191,"interventions":192},[],[171,172],[148,174],{"intervention":194,"totalTrials":54,"cells":195},"Agomelatine 25 MG Oral",{"EARLY_PHASE1":196,"PHASE1":198,"PHASE2":200,"PHASE3":202,"PHASE4":204,"NA":206},{"trials":197,"activeCount":9},[],{"trials":199,"activeCount":9},[],{"trials":201,"activeCount":9},[],{"trials":203,"activeCount":9},[],{"trials":205,"activeCount":9},[],{"trials":207,"activeCount":9},[208],{"nctId":209,"briefTitle":210,"status":165,"phases":211,"primaryCompletion":212,"completion":213,"start":214,"enrollment":215,"conditions":216,"interventions":218},"NCT03193112","Melatonin Decreases Eye Pressure in Normotensive Patients",[],"2017-10-15","2018-06-15","2017-06-16",20,[217],"Depressive Disorder",[194],{"intervention":220,"totalTrials":54,"cells":221},"Botulinum Toxin A",{"EARLY_PHASE1":222,"PHASE1":224,"PHASE2":226,"PHASE3":228,"PHASE4":230,"NA":232},{"trials":223,"activeCount":9},[],{"trials":225,"activeCount":9},[],{"trials":227,"activeCount":9},[],{"trials":229,"activeCount":9},[],{"trials":231,"activeCount":9},[],{"trials":233,"activeCount":9},[234],{"nctId":235,"briefTitle":236,"status":165,"phases":237,"primaryCompletion":238,"completion":238,"start":239,"enrollment":240,"conditions":241,"interventions":245},"NCT07545200","Ultrasonographic Evaluation of Masseter Muscle Changes After Botulinum Toxin Injection in Bruxism Patients",[51],"2026-02-15","2025-09-30",17,[242,243,244],"Bruxism","Myofascial Pain","Masseter Muscle Hypertrophy",[220],{"intervention":247,"totalTrials":54,"cells":248},"Injectable Platelet-Rich Fibrin",{"EARLY_PHASE1":249,"PHASE1":251,"PHASE2":253,"PHASE3":255,"PHASE4":257,"NA":259},{"trials":250,"activeCount":9},[],{"trials":252,"activeCount":9},[],{"trials":254,"activeCount":9},[],{"trials":256,"activeCount":9},[],{"trials":258,"activeCount":9},[],{"trials":260,"activeCount":9},[261],{"nctId":262,"briefTitle":263,"status":165,"phases":264,"primaryCompletion":38,"completion":38,"start":265,"enrollment":266,"conditions":267,"interventions":269},"NCT07303192","Effect of i-PRF and LLLT on Free Gingival Graft Shrinkage",[51],"2024-07-01",48,[268,115],"Graft Shrinkage",[247]]